You searched for lung cancer | Page 37 of 166

Exai Bio’s RNA-Based Liquid Biopsy Platform Detects Early Stage Breast Cancer Accurately

Posted by Andy Lundin | Dec 8, 2023 | Breast |

Exai Bio’s liquid biopsy platform can detect breast cancer at the earliest stages and the smallest tumor sizes using a standard blood sample.

Posted by Andy Lundin | Dec 5, 2023 | Cancer |

UCLA Researchers received $9.1 million in grant funding from the National Cancer Institute to advance liquid biopsy tech for cancer detection.

Posted by Andy Lundin | Dec 4, 2023 | Cancer, Company News |

Personalis and Tempus Labs announced a collaboration to co-commercialize a whole genome-based liquid biopsy LDT for MRD and cancer detection.

Posted by Andy Lundin | Dec 1, 2023 | Lung Cancer, Swabs |

Clinical validation data shows that Veracyte’s Percepta Nasal Swab test determines lung cancer risk with high accuracy for certain patients.

Consolidation, legislation, new testing types, and a shift to more consumer-driven testing are some clinical laboratory predictions for 2024.